Reprogramming the Tolerogenic Immune Response Against Pancreatic Cancer Metastases by Lipid Nanoparticles Delivering a STING Agonist Plus Mutant KRAS mRNA

By sjmartinez • March 3, 2025

Xu X, Wang X, Liao YP, Luo L, Nel AE. Reprogramming the Tolerogenic Immune Response Against Pancreatic Cancer Metastases by Lipid Nanoparticles Delivering a STING Agonist Plus Mutant KRAS mRNA. ACS Nano. 2025 Mar 2. doi: 10.1021/acsnano.4c14102. Epub ahead of print. PMID: 40025875.

Tags: cancer vaccine, lipid nanoparticles, liver metastasis, mRNA delivery, Nano Medicine, pancreatic cancer, Post Doc, Publications

Correction: Reduction of pulmonary toxicity of metal oxide nanoparticles by phosphonate-based surface passivation

Cai X, Lee A, Ji Z, Huang C, Chang CH, Wang X, Liao YP, Xia T, Li R. Correction: Reduction of pulmonary toxicity of metal[...]

Role of ESCCAL-1 in regulating exocytosis of AuNPs in human esophageal squamous carcinoma cells

Gong F, Cui Y, Lv P, Liu J, Sun X, Han P, Zhou L, Xia T, Cao W. Role of ESCCAL-1 in regulating exocytosis of[...]

Reprogramming the pancreatic cancer stroma and immune landscape by a silicasome nanocarrier delivering nintedanib, a protein tyrosine kinase inhibitor

Luo L, Wang X, Liao YP, Xu X, Chang CH, Nel AE. Reprogramming the pancreatic cancer stroma and immune landscape by a silicasome nanocarrier delivering[...]